Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
42.3M
-
Shares change
-
-2.32M
-
Total reported value, excl. options
-
$104M
-
Value change
-
-$6.36M
-
Number of buys
-
38
-
Number of sells
-
-32
-
Price
-
$2.45
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2015
98 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2015.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.3M shares
of 123M outstanding shares and own 34.37% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (8.28M shares), FEDERATED INVESTORS INC /PA/ (4.58M shares), Broadfin Capital, LLC (4.18M shares), Consonance Capital Management LP (2.89M shares), VANGUARD GROUP INC (2.6M shares), Point72 Asset Management, L.P. (2.28M shares), FRANKLIN RESOURCES INC (2.13M shares), BlackRock Fund Advisors (2.04M shares), SPHERA FUNDS MANAGEMENT LTD. (1.46M shares), and STATE STREET CORP (1.13M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.